We are a microfluidic tool company based in San Diego, CA, USA, and are actively involved in developing next generation bioanalytical microfluidic tools for life sciences research and applications such as immunoassays, 2D/3D/suspension cell culture and drug screening, small animal screening, organ-on-chip etc. You can also visit our website at www.neofluidics.com to get more information on our technology.

We have been working with several small/big pharma/biotech companies and academic institutions for the past several years. Other than providing the tools/systems based on our proprietary technology, we also collaborate effectively to address custom application needs. For example, we are working with Pfizer, La Jolla to develop a dynamic PKPD setup for 2D/3D cultured cells or suspension cells with the ultimate goal of translating clinical profiles to a more relevant in-vitro drug discovery model. I would like to share an interesting story which Pfizer published on harnessing the potential of Neofluidics’ Microfluidic Platform Technology for the Next Generation Drug Discovery.

https://www.getscience.com/content/better-faster-smaller-how-advance-microfluidics-can-speed-drug-discovery
https://www.nasdaq.com/article/neofluidics-enters-collaboration-with-pfizer—quick-facts-20180302-00225